Research in the Schizophrenia Division is broad and includes studies on improving therapeutic and assessment approaches, management of side effects, enhancing patient recovery, as well identifying risk factors and causes to intervene early and develop new treatments. Our core research faculty has diverse interests and expertise in clinical treatment trials, metabolic risks, psychopharmacology, virtual reality, genetics and pharmacogenetics, neuropsychology, brain physiology and imaging, molecular biology and neuroinformatics. Together, we have created a research program that exemplifies a modern, translational approach to research on schizophrenia with the aim of better understanding, treating and preventing schizophrenia.
